N. Eisemann, A. Waldmann, A. C. Geller, M. A. Weinstock, B. Volkmer et al., Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence, J. Invest. Dermatol, vol.134, pp.43-50, 2014.

K. G. Paulson, S. Y. Park, N. A. Vandeven, K. Lachance, H. Thomas et al., Merkel cell carcinoma: current US incidence and projected increases based on changing demographics, J. Am. Acad. Dermatol, vol.78, pp.457-463, 2018.

M. Agelli and L. X. Clegg, Epidemiology of primary Merkel cell carcinoma in the United States, J. Am. Acad. Dermatol, vol.49, pp.832-841, 2003.

H. Feng, M. Shuda, Y. Chang, and P. S. Moore, Clonal integration of a polyomavirus in human Merkel cell carcinoma, Science, vol.319, pp.1096-1100, 2008.

J. A. Wendzicki, P. S. Moore, and Y. Chang, Large T and small T antigens of Merkel cell polyomavirus, Curr. Opin. Virol, vol.11, pp.38-43, 2015.

V. Foulongne, O. Dereure, N. Kluger, J. P. Molès, B. Guillot et al., Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases, Br. J. Dermatol, vol.162, pp.59-63, 2010.

D. V. Pastrana, U. Wieland, S. Silling, C. B. Buck, and H. Pfister, Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer, Med. Microbiol. Immunol, vol.201, pp.17-23, 2012.

M. Shuda, H. Feng, H. J. Kwun, S. T. Rosen, O. Gjoerup et al., T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus, Proc. Natl. Acad. Sci. U.S.A, vol.105, pp.16272-16277, 2008.

M. Shuda, R. Arora, H. J. Kwun, H. Feng, R. Sarid et al., Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors, Int. J. Cancer, vol.125, pp.1243-1249, 2009.

M. Shuda, H. J. Kwun, H. Feng, Y. Chang, and P. S. Moore, Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator, J. Clin. Invest, vol.121, pp.3623-3634, 2011.

G. Goh, T. Walradt, V. Markarov, A. Blom, N. Riaz et al., Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy, vol.7, pp.3403-3415, 2016.

K. L. Harms, M. A. Healy, P. Nghiem, A. J. Sober, T. M. Johnson et al., Analysis of prognostic factors from 9387 merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system, Ann. Surg. Oncol, vol.23, pp.3564-3571, 2016.

M. Samimi, Immune checkpoint inhibitors and beyond: an overview of immunebased therapies in merkel cell carcinoma, Am. J. Clin. Dermatol, vol.78, pp.2-17, 2019.

C. K. Bichakjian, T. Olencki, S. Z. Aasi, M. Alam, J. S. Andersen et al., Merkel cell carcinoma, version 1.2018, NCCN clinical practice guidelines in oncology, J. Natl. Compr. Cancer Netw, vol.16, pp.742-774, 2018.

H. L. Kaufman, J. Russell, O. Hamid, S. Bhatia, P. Terheyden et al., Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial, Lancet Oncol, vol.17, pp.30364-30367, 2016.

P. Nghiem, S. Bhatia, E. J. Lipson, W. H. Sharfman, R. R. Kudchadkar et al., Durable tumor regression and overall survival in patients with advanced merkel cell carcinoma receiving pembrolizumab as first-line therapy, J. Clin. Oncol, vol.37, pp.693-702, 2019.

K. G. Paulson, J. G. Iyer, W. T. Simonson, A. Blom, R. M. Thibodeau et al., CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study, Am. J. Clin. Pathol, vol.142, pp.452-458, 2014.

H. Sihto, T. Böhling, H. Kavola, V. Koljonen, M. Salmi et al., Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study, Clin. Cancer Res, vol.18, pp.2872-2881, 2012.

N. J. Miller, C. D. Church, L. Dong, D. Crispin, M. P. Fitzgibbon et al., Tumor-infiltrating merkel cell polyomavirus-specific T cells are diverse and associated with improved patient survival, Cancer Immunol Res, vol.5, pp.137-147, 2017.

J. G. Iyer, O. K. Afanasiev, C. Mcclurkan, K. Paulson, K. Nagase et al., Merkel cell polyomavirus-specific CD8 + and CD4

, + T-cell responses identified in Merkel cell carcinomas and blood, vol.17, pp.6671-6680, 2011.

Q. Zeng, B. P. Gomez, R. P. Viscidi, S. Peng, L. He et al., Development of a DNA vaccine targeting Merkel cell polyomavirus, Vaccine, vol.30, pp.1322-1329, 2012.

R. Lyngaa, N. W. Pedersen, D. Schrama, C. A. Thrue, D. Ibrani et al., T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors, Clin. Cancer Res, vol.20, pp.1768-1778, 2014.

A. G. Chapuis, O. K. Afanasiev, J. G. Iyer, K. G. Paulson, U. Parvathaneni et al., Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I, Cancer Immunol. Res, vol.2, pp.27-36, 2014.

N. J. Miller, C. D. Church, S. P. Fling, R. Kulikauskas, N. Ramchurren et al., Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy, J. Immunother. Cancer, vol.6, 2018.

M. Van-gele, M. Kaghad, J. H. Leonard, N. Van-roy, J. M. Naeyaert et al., Mutation analysis of P73 and TP53 in Merkel cell carcinoma, Br. J. Cancer, vol.82, pp.823-826, 2000.

H. Benlalam, N. Labarriere, B. Linard, L. Derre, E. Diez et al., Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy, Eur. J. Immunol, vol.31, 2001.

O. Boccara, C. Girard, L. Mortier, G. Bens, P. Saiag et al., Guidelines for the diagnosis and treatment of Merkel cell carcinoma -cutaneous oncology group of the french society of dermatology, Eur. J. Dermatol, vol.22, pp.375-379, 2012.

K. G. Paulson, J. G. Iyer, A. Blom, E. M. Warton, M. Sokil et al., Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage, J. Invest. Dermatol, vol.133, pp.642-646, 2013.

T. Kervarrec, A. Tallet, E. Miquelestorena-standley, R. Houben, D. Schrama et al., Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas, Mod. Pathol, vol.32, pp.499-510, 2019.

M. Samimi, L. Molet, M. Fleury, H. Laude, A. Carlotti et al., Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma, Br. J. Dermatol, vol.174, pp.813-822, 2016.

F. Jotereau, M. C. Pandolfino, D. Boudart, E. Diez, B. Dreno et al., High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy, J. Immunother, vol.10, pp.405-411, 1991.

M. C. Pandolfino, N. Labarriere, M. H. Tessier, A. Cassidanius, S. Bercegeay et al., High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, Cancer Immunol. Immunother, vol.50, pp.134-140, 2001.

N. Gervois, N. Labarriere, S. L. Guiner, M. C. Pandolfino, J. F. Fonteneau et al., High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptidepulsed melanoma cells, Clin. Cancer Res, vol.6, pp.1459-1467, 2000.

S. T. Rosen, V. E. Gould, H. R. Salwen, C. V. Herst, M. M. Beau et al., Establishment and characterization of a neuroendocrine skin carcinoma cell line, Lab. Invest, vol.56, pp.302-312, 1987.

A. Guastafierro, H. Feng, M. Thant, J. M. Kirkwood, Y. Chang et al., Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice, J. Virol. Meth, vol.187, pp.6-14, 2013.

M. Van-gele, J. H. Leonard, N. Van-roy, H. Van-limbergen, S. Van-belle et al., Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma, Int. J. Cancer, vol.101, pp.137-145, 2002.

R. Houben, M. Shuda, R. Weinkam, D. Schrama, H. Feng et al., Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens, J. Virol, vol.84, pp.7064-7072, 2010.

R. Houben, C. Dreher, S. Angermeyer, A. Borst, J. Utikal et al., Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens, J. Invest. Dermatol, vol.133, pp.2453-2460, 2013.

A. Moreau-aubry, S. L. Guiner, N. Labarriere, M. C. Gesnel, F. Jotereau et al., A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma, J. Exp. Med, vol.191, pp.1617-1624, 2000.

Y. Guilloux, S. Lucas, V. G. Brichard, A. Van-pel, C. Viret et al., A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene, J. Exp. Med, vol.183, pp.1173-1183, 1996.

Y. Godet, A. Moreau-aubry, Y. Guilloux, V. Vignard, A. Khammari et al., MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency, J. Exp. Med, vol.205, pp.2673-2682, 2008.

E. De-plaen, C. Lurquin, B. Lethé, P. Van-der-bruggen, V. Brichard et al., Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes, Methods, vol.12, pp.125-142, 1997.

J. A. Mccutcheon, J. Gumperz, K. D. Smith, C. T. Lutz, and P. Parham, Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA, J. Exp. Med, vol.181, pp.2085-2095, 1995.

J. Zemmour and P. Parham, Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C, J. Exp. Med, vol.176, pp.937-950, 1992.

A. Michaux, P. Larrieu, V. Stroobant, J. Fonteneau, F. Jotereau et al., A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming, J. Immunol, vol.192, pp.1962-1971, 2014.

K. G. Paulson, V. Voillet, M. S. Mcafee, D. S. Hunter, F. D. Wagener et al., Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA, Nat. Commun, vol.9, 2018.

I. Gavvovidis, M. Leisegang, G. Willimsky, N. Miller, P. Nghiem et al., Targeting merkel cell carcinoma by engineered T cells specific to T-antigens of merkel cell polyomavirus, Clin. Cancer Res, vol.24, pp.3644-3655, 2018.

E. J. Wherry and M. Kurachi, Molecular and cellular insights into T cell exhaustion, Nat. Rev. Immunol, vol.15, pp.486-499, 2015.

M. Dowlatshahi, V. Huang, A. E. Gehad, Y. Jiang, A. Calarese et al., Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses, J. Invest. Dermatol, vol.133, pp.1879-1889, 2013.

P. W. Harms, P. Vats, M. E. Verhaegen, D. R. Robinson, Y. Wu et al., The distinctive mutational spectra of polyomavirus-negative Merkel cell carcinoma, Cancer Res, vol.75, pp.3720-3727, 2015.